Stay updated on T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Sign up to get notified when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The new screenshot shows updated header/banner styling and minor layout tweaks to the version history list, while the core information (version dates and changes) remains the same. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-11-03T21:00:56.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    - Added a government operating status notice and a version bump to v3.2.0. - Removed the old version tag v3.1.0.
    Difference
    12%
    Check dated 2025-10-06T05:35:53.000Z thumbnail image
  4. Check
    40 days ago
    Change Detected
    Summary
    - Updated the page version from v3.0.2 to v3.1.0. Minor overall impact, mainly reflects a version increment.
    Difference
    0.3%
    Check dated 2025-09-29T03:06:21.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Updated Revision: v3.0.2 (replacing v3.0.1); removed the 'Back to Top' element.
    Difference
    0.7%
    Check dated 2025-09-14T19:24:19.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.7%
    Check dated 2025-09-07T16:43:27.000Z thumbnail image
  7. Check
    69 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and specific study statuses with corresponding dates, while several location-related terms have been removed.
    Difference
    20%
    Check dated 2025-08-31T12:04:23.000Z thumbnail image

Stay in the know with updates to T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the T-DM1+Pertuzumab in HER2+ BRCA Clinical Trial page.